Parkinson's Disease Clinical Trials in San Francisco, California

4 studies are recruiting for parkinson's disease in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Parkinson's Foundation PD GENEration Genetic Registry

    Development of a central repository for PD-related genomic data for future research.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of California San Francisco (UCSF), San Francisco, California
    Locations
    70 in total
    Run by
    Parkinson's Foundation

    See if you can join NCT04994015 on ClinicalTrials.gov

  2. A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

    The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with early-stage Parkinson's disease (PD) on stable symptomatic monotherapy with levodopa.

    Stage
    Phase 3
    Ages
    50 to 85
    Site
    UCSF Weill Institute for Neurosciences, San Francisco, California
    Locations
    192 in total
    Run by
    Hoffmann-La Roche

    See if you can join NCT07174310 on ClinicalTrials.gov

  3. Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease

    Parkinson's disease (PD) is a brain disorder that causes progressive problems with movement, such as slowness, stiffness, tremor, and difficulty walking. Many people with PD also develop problems with thinking and memory. Current medications can help control movement symptoms but often become less …

    Stage
    Not phased
    Ages
    50 to 90
    Site
    San Francisco Neurology and Sleep Center, San Francisco, California
    Run by
    San Francisco Neurology and Sleep Center

    See if you can join NCT07554833 on ClinicalTrials.gov

  4. Ketamine for Veterans With Parkinson's Disease

    Parkinson's disease (PD) is a devastating illness that has a growing impact on Veterans. One of the most disabling symptoms is depression, which is common in PD and linked to poor quality of life and higher risk of suicide. Unfortunately, there is a lack of effective treatments for depression in PD…

    Stage
    Phase 2
    Ages
    40 to 80
    Site
    San Francisco VA Medical Center, San Francisco, CA, San Francisco, California
    Run by
    VA Office of Research and Development

    See if you can join NCT06231563 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.